Status:

UNKNOWN

OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage - Pilot Study

Lead Sponsor:

McMaster University

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Conditions:

Traumatic Intracranial Haemorrhage

Eligibility:

All Genders

16+ years

Phase:

NA

Brief Summary

Victims of trauma with severe head injury who have bled into their brains are at high risk of developing blood clots in their legs. These blood clots can break off and travel through the bloodstream t...

Eligibility Criteria

Inclusion

  • Multi-system trauma patients referred to the trauma service with a non-progressing tICH documented on 24-hour repeat head CT scan

Exclusion

  • Unexpected to survive or remain in hospital \>72 hours
  • Known malignancy under active care at time of admission
  • Known DVT, PE or other condition requiring anticoagulation at time of admission
  • Coagulopathy (defined as international normalized ratio (INR) values \>1.5 times the upper limit of normal, or partial thromboplastin time (PTT) values \>1.5 times the upper limit of normal) at 24 hours after admission
  • Platelet count \<75 x 10\^9/L at 24 hours after admission
  • Bilateral lower limb amputation
  • History of allergy to heparin or suspected or proven HIT
  • Limitation of life support or palliative care
  • Prior enrollment in this trial or currently in a confounding randomized trial
  • Pregnancy
  • Study drug (LMWH or placebo) not administered within 36-48 hours post-injury
  • Grade V liver or splenic injuries that have not received definitive care (e.g. embolization, surgical intervention) within 36-48 hours after injury
  • Persistent intracranial pressure \>20 mm Hg
  • Spinal subdural haematoma or spinal epidural haematoma
  • Intracranial haemorrhage progression on 24-hour repeat CT scan

Key Trial Info

Start Date :

October 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2016

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT02260908

Start Date

October 1 2014

End Date

September 1 2016

Last Update

April 10 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hamilton Health Sciences- General site

Hamilton, Ontario, Canada, L8L 2X2